By Dave Fornell, DAIC editor
The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 4, 2013 — According to a study of diabetic patients who underwent revascularization for multivessel coronary ...
November 04, 2013
November 4, 2013 — A new study demonstrated that some patients may not need to receive prolonged anti-clotting therapy ...
November 04, 2013
November 4, 2013 — Patients who do not experience a major cardiac event in the first year after receiving drug-eluting ...
November 04, 2013
November 4, 2013 — According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention ...
November 04, 2013
November 1, 2013 — According to a new study, administering the blood thinner bivalirudin to patients experiencing an ST ...
November 01, 2013
October 31, 2013 — Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate ...
October 31, 2013October 24, 2013 – PDI, Inc. and Transgenomic, Inc. announced the signing of a U.S. collaboration agreement to ...
October 24, 2013
October 2, 2013 — Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol ...
October 02, 2013Oct. 1, 2013 – The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report ...
October 01, 2013September 30, 2013—A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per ...
September 30, 2013
September 26, 2013 — Lead study investigators from Icahn School of Medicine at Mount Sinai presented their Patterns of ...
September 26, 2013September 23, 2013 – Aggredyne Inc., has received ISO 13485 certification for its quality control program related to the ...
September 23, 2013September 18, 2013 — Decision Resources forecasts that Bayer/Janssen's Xarelto will be the sales-leading therapy among ...
September 18, 2013September 13, 2013 — Atherotech Diagnostics Lab has added three new genetic tests to its cardiometabolic test offering ...
September 13, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now